<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04935736</url>
  </required_header>
  <id_info>
    <org_study_id>CORT-SP</org_study_id>
    <secondary_id>2021-A00525-36</secondary_id>
    <nct_id>NCT04935736</nct_id>
  </id_info>
  <brief_title>Postoperative Pain After Root Canal Obturation With Sealer Containing Prednisolone.</brief_title>
  <official_title>Postoperative Pain Evaluation After Definitive Root Canal Obturation With Zinc Oxide/Eugenol-type Sealer Containing or Not 1% Prednisolone Acetate - Steroid Anti-inflammatory Agent: a Comparative, Randomized Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ACTEON Group</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Slb Pharma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ACTEON Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study design is a multicentric randomized controlled clinical trial. 238 subjects (teeth)&#xD;
      requiring a primary or a secondary root canal treatment will be enrolled in 2 groups (119 in&#xD;
      each group).&#xD;
&#xD;
      The aim is to assess the effectiveness and utility of the ancillary drug substance,&#xD;
      prednisolone acetate (1%) contained in CORTISOMOL SP (Zinc Oxide/Eugenol-type sealer) to help&#xD;
      to decrease the possible postoperative painful reactions after root canal treatment. SEALITE&#xD;
      REGULAR, which has a similar formulation except it is prednisolone acetate-free, is used as&#xD;
      the comparator sealer.&#xD;
&#xD;
      Procedures of root canal treatment will be conventional and standardized for all&#xD;
      investigational centers. The canals will be cleaned, shaped and then obturated using a Zinc&#xD;
      oxide/Eugenol-type sealer (CORTISOMOL SP or SEALITE REGULAR) and gutta-percha.&#xD;
&#xD;
      Patients assess their pain for 7 days after permanent root canal obturation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 30, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Study subject (tooth) will be randomized in a 1:1 allocation ratio between the 2 treatment groups.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>the participant will be blind from the treatment</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative pain assessed by a VAS</measure>
    <time_frame>From the end of the root canal treatment (Day 0) to Day 7</time_frame>
    <description>The pain is assessed by patients in a diary using a Visual Analogue Scale (range from 0 (= no pain) to 100 (= the worst pain)) at different times after endodontic treatment from the end of the root canal obturation to Day 7. The maximum pain felt will be compared between the 2 groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Use of oral pain treatment</measure>
    <time_frame>From the end of the root canal treatment (Day 0) to Day 7</time_frame>
    <description>Patients reported the consumption of analgesic treatment in a diary. The proportion of patients who took oral pain medication will be compared between the 2 groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of adverse events</measure>
    <time_frame>From the end of the root canal treatment (Day 0) to the end of follow-up visit (Day 14)</time_frame>
    <description>Adverse events recorded from the endodontic treatment to the end of follow-up visit will be used to assess the safety of root canal sealers and endodontic procedures.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">238</enrollment>
  <condition>Root Canal Obturation</condition>
  <arm_group>
    <arm_group_label>CORTISOMOL SP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Zinc oxide/Eugenol-type sealer containing 1% Prednisolone Acetate. The sealer is used in combination with gutta percha points for the permanent obturation of root canals.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SEALITE REGULAR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Zinc oxide/Eugenol-type sealer is used in combination with gutta percha points for the permanent obturation of root canals.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>root canal sealer : CORTISOMOL SP</intervention_name>
    <description>The participant will be treated with CORTISOMOL SP sealer in combination with gutta percha.</description>
    <arm_group_label>CORTISOMOL SP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>root canal sealer : SEALITE REGULAR</intervention_name>
    <description>The participant will be treated with SEALITE REGULAR sealer in combination with gutta percha.</description>
    <arm_group_label>SEALITE REGULAR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female, age &gt; 18 years old&#xD;
&#xD;
          -  Patient requiring a primary or a secondary root canal treatment on a single or&#xD;
             multi-rooted tooth.&#xD;
&#xD;
          -  Informed consent signed&#xD;
&#xD;
          -  Patient with social protection.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Endodontic treatment on tooth with suspected root perforation, or immature tooth,&#xD;
&#xD;
          -  Known allergy to corticosteroids, local anesthetics, or any component of the medical&#xD;
             devices,&#xD;
&#xD;
          -  Patient taking anti-pain or anti-inflammatory treatment regularly for another&#xD;
             pathology,&#xD;
&#xD;
          -  Presence of any significant medical finding or significant history such as&#xD;
             uncontrolled systemic diseases that may impact the safety, the interpretation of the&#xD;
             results and/or the participation of the subject in the study according to the opinion&#xD;
             of the investigator,&#xD;
&#xD;
          -  Participation in another intervnetional clinical trial or subject still within the&#xD;
             exclusion period of a previous clinical trial,&#xD;
&#xD;
          -  Vulnerable subjects referred to in articles L.1121-5 to 8 and L.1122-1-2 of the Public&#xD;
             Health Code and article 66 of Regulation (EU) 2017/745 on medical devices are excluded&#xD;
             from the investigation (such as known pregnancy or lactation, patients with legal&#xD;
             protection).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hugues Colombel, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cabinet dentaire (Rennes)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne-Laure Sérandour, PhD</last_name>
    <phone>+33(0)299121962</phone>
    <email>al.serandour@slbpharma.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vincent Maurat</last_name>
    <phone>+33(0)556 349301</phone>
    <email>vincent.maurat@acteongroup.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Lamballe</city>
        <zip>22400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline Leclercq, DDS</last_name>
    </contact>
    <investigator>
      <last_name>Caroline Leclercq, DDS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bertrand Leclercq, DDS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Liffré</city>
        <zip>35340</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien Cardona, DDS</last_name>
    </contact>
    <investigator>
      <last_name>Julien Cardona, DDS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Pluguffan</city>
        <zip>29700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphane Cano, DDS</last_name>
    </contact>
    <investigator>
      <last_name>Stéphane Cano, DDS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gwenolé Huon, DDS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Plédran</city>
        <zip>22960</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Myriam Rouxel, DDS</last_name>
    </contact>
    <investigator>
      <last_name>Myriam Rouxel, DDS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hugues Colombel, DDS</last_name>
    </contact>
    <investigator>
      <last_name>Hugues Colombel, DDS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hugo Abgrall, DDS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincent Bar, DDS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Rennes - Centre de Soins Dentaires</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Le Goff, DDS</last_name>
    </contact>
    <investigator>
      <last_name>Anne Le Goff, DDS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Saint-Brieuc</city>
        <zip>22000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal Rouxel, DDS</last_name>
    </contact>
    <investigator>
      <last_name>Pascal Rouxel, DDS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Saint-Coulomb</city>
        <zip>35350</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Sestié, DDS</last_name>
    </contact>
    <investigator>
      <last_name>Christophe Sestié, DDS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 9, 2021</study_first_submitted>
  <study_first_submitted_qc>June 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2021</study_first_posted>
  <last_update_submitted>July 2, 2021</last_update_submitted>
  <last_update_submitted_qc>July 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>endodontic treatment</keyword>
  <keyword>root canal sealer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

